GENEVA, Oct. 28 -- ELI LILLY AND COMPANY (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/025174) for "GLUCAGON RECEPTOR AGONISTS AND THEIR USE AS THERAPIES" on Apr 17, 2025. With publication no. WO/2025/222008, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANTHONY, Sarah May (c/o Eli Lilly and CompanyPO Box 6288Indianapolis, Indiana 46206-6288), BUCHANAN, Travis Lamonte (c/o Eli Lilly and CompanyPO Box 6288Indianapolis, Indiana 46206-6288), CONNER, Scott Eugene (c/o Eli Lilly a...